Head and Neck Cancer
Commissioned by the NHS England cancer programme team, this workstream has focused on supporting England’s Cancer Alliances to better provide timely, equitable and effective care which delivers the best possible outcomes for both patients and NHS colleagues.
There are around 12,500 new cases of head and neck cancer diagnosed in the UK each year. The term ‘head and neck’ encompasses more than 30 areas where cancer can develop, including the mouth and lips, voice box (larynx), throat (pharynx), nose and sinuses and the area at the back of the nose and mouth (nasopharynx).
The GIRFT review covered organisational issues, such as multidisciplinary team (MDT) working and workforce, as well as specific stages along the pathway, including improving the patient’s time to diagnosis and treatment.
- Head and Neck Cancer Clinical Leads
Dr Camilla Dawson
Head and neck cancer joint clinical lead
Jennifer Graystone
Head and neck cancer joint clinical lead
Dr Ketan Shah
Head and neck cancer joint clinical lead
Lorna MacNab
Head and neck cancer joint clinical lead
- Former Head and Neck Cancer Clinical Leads
Martin Ashley
Head and neck cancer joint clinical lead
Martin Heaton
Head and neck cancer joint clinical lead
Professor Jarrod Homer
Head and neck cancer joint clinical lead
Long Li
Head and neck cancer joint clinical lead
Amanda Naylor
Head and neck cancer joint clinical lead
Find out more about GIRFT’s data-led approach and best practice resources:
- Head and Neck Cancer National Report
- Head and Neck Cancer News